IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
Prevest Denpro IPO is a Book Building listing on BSE SME exchange. The company is based in Jammu and caters to Healthcare sector. Hem Securities is the merchant banker of Prevest Denpro IPO. It is a SME IPO which filed its Draft Red Herring Prospectus (DRHP) on 3rd September 2021.
Prevest Denpro IPO posted revenues of ₹ 29.51 crores and PAT of ₹ 7.44 crores in FY00 on annualised basis.
Revenue:
₹ 27.44 Cr.
EBITDA Margin:
36.52
% 
Net Worth: ₹ 22.75 Cr.
Market Capitalisation:
₹ 100.81 Cr.
P/E:
13.55 times
P/BV: 2.04 times
EV/EBITDA: 8.56 times
Financial results of Prevest Denpro IPO based on restated financials as per prospectus and IPO review parameters can be referred to below.
| Financials | FY21 | FY20 | FY19 | ||
|---|---|---|---|---|---|
|
Balance Sheet
|
|||||
| Assets | 30.70 | 21.08 | 15.34 | ||
| Net Worth | 22.75 | 15.31 | 10.30 | ||
| Total Debt | 1.39 | 1.59 | 1.39 | ||
|
Profit & Loss
|
|||||
Revenue
Revenue on annualised basis |
27.44 | 22.77 | 19.28 | ||
EBITDA
EBITDA on annualised basis |
10.02 | 6.89 | 4.31 | ||
PAT
PAT on annualised basis |
7.44 | 5.01 | 2.99 | ||
Prevest Denpro IPO PAT Margin is 27.11 % , ROCE (Return on Capital Employed) is [●] % as per latest financial. The below table shows Prevest Denpro IPO Key Performance Indicators (KPI) as mentioned in company’s prospectus.
| Particulars | FY21 | FY20 | FY19 |
|---|---|---|---|
| EBITDA Margin (%) | 36.52 | 30.26 | 22.35 |
| PAT Margin (%) | 27.11 | 22.00 | 15.51 |
| EPS (₹) | 8.42 | 5.67 | 3.39 |
| ROE (%) | 32.70 | 32.72 | 29.03 |
| ROCE (%) | [●] | [●] | [●] |
| ROA (%) | 24.23 | 23.77 | 19.49 |
| Debt to Equity | 0.06 | 0.10 | 0.13 |
The market Capitalisation of Prevest Denpro IPO is ₹ 100.81 crores at the time of IPO and other IPO valuation metrics of this IPO is mentioned below.
The Prevest Denpro IPO prospectus highlights an Return on Equity (ROE) of 15 %, Return on Assets (ROA) of 12 %, and an EBITDA Margin of 18 %, showcasing financial performance.
Profitability ratios like Return on Equity (ROE), Return on Assets (ROA), and Net Profit Margin shows Prevest Denpro IPO financial report. Analysing these metrics can provide insights into the company’s efficiency, profitability, and long-term growth potential.
The post-IPO market capitalisation of Prevest Denpro IPO is ₹ 100.81 Cr., based on the issue price and share structure. It helps investors gauge the company’s valuation and compare it with industry peers before investing.
The Prevest Denpro IPO has a Price-to-Earnings (PE) ratio of 13.55 X, indicating valuation compared to industry peers. It helps investors determine if the stock is overvalued or undervalued compared to its earnings and industry peers.
Prevest Denpro IPO reported revenue of ₹ 29.51 Cr. in the latest fiscal year, showing business performance, on annualised basis. Revenue figures from Prevest Denpro IPO provide insights into sales growth, market demand, and business scalability.
Prevest Denpro recorded an EBITDA of ₹ 10.02 Cr., reflecting operational efficiency. EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortisation) measures operational profitability.
Prevest Denpro Profit After Tax (PAT) is ₹ 7.44 Cr., reflecting earnings growth. Profit After Tax (PAT) reflects the company’s actual earnings after all expenses, taxes, and deductions
Revenue:
₹ 27.44 Cr.
EBITDA Margin:
36.52
%
Net Worth: ₹ 22.75 Cr.
Market Capitalisation:
₹ 100.81 Cr.
P/E:
13.55 times
P/BV: 2.04 times
EV/EBITDA: 8.56 times
Prevest Denpro operates in Healthcare and Healthcare. The Issue is listed on BSE SME in Sep, 2021. Prevest Denpro IPO size was 26.61 with Issue price of 84.00 .
Merchant Banker(s) of Prevest Denpro IPO: Hem Securities Limited
Prevest Denpro IPO subscription was 38.12 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Prevest Denpro IPO listed at a listing price of 189.55 against the offer price of 84.00.
The current market price of Prevest Denpro is 470.15.
Why Us?
